A detailed history of Alpha Core Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Alpha Core Capital LLC holds 1,904 shares of ABT stock, worth $213,838. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,904
Holding current value
$213,838
% of portfolio
0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $190,533 - $224,919
1,904 New
1,904 $217,000
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $20,151 - $22,256
184 Added 6.92%
2,844 $323,000
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $58,082 - $71,097
-644 Reduced 19.49%
2,660 $292,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $315,631 - $378,704
3,304 New
3,304 $319,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $32,082 - $41,062
-419 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $26,321 - $38,489
419 New
419 $33,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Alpha Core Capital LLC Portfolio

Follow Alpha Core Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Core Capital LLC with notifications on news.